Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older.
about
Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club.Efficacy of Osteoporosis Therapies in Diabetic Patients.Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone ClubStrontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal.Management of osteoporosis in patients hospitalized for hip fracturesStrontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacyStrontium ranelate effect on bone mineral density is modified by previous bisphosphonate treatment.Strontium ranelate improves bone microarchitecture in osteoporosis.Treatment of osteopenia.Efficacy of strontium ranelate in combination with a D-hormone analog for the treatment of postmenopausal osteoporosis.Enhancement of orthodontic anchorage and retention by the local injection of strontium: An experimental study in rats.Porous allograft bone scaffolds: doping with strontium.Microarchitecture and nanomechanical properties of trabecular bone after strontium administration in osteoporotic goats.A Strontium-Modified Titanium Surface Produced by a New Method and Its Biocompatibility In Vitro.Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS).Strontium Ranelate: Long-Term Efficacy against Vertebral, Nonvertebral and Hip Fractures in Patients with Postmenopausal Osteoporosis.Interaction between bone and muscle in older persons with mobility limitationsSr-substituted bone cements direct mesenchymal stem cells, osteoblasts and osteoclasts fate.Pharmacological treatments for osteoporosis in very elderly people.Strontium ranelate: short- and long-term benefits for post-menopausal women with osteoporosisThe role of DXA bone density scans in the diagnosis and treatment of osteoporosis.Emerging pharmacologic therapies for osteoporosis.A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis.Management of osteoporosis among the elderly with other chronic medical conditionsDiagnosis and management of osteoporosis in the older seniorEffect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density.Progress in osteoporosis and fracture prevention: focus on postmenopausal women.Current, new and future treatments of osteoporosis.Strontium ranelate: a look back at its use for osteoporosis.Current and future treatment options in osteoporosis.Current options for the management of postmenopausal osteoporosis.Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments.New developments in the treatment of osteoporosis.Osteoporosis in older persons: current pharmacotherapy and future directions.Management of osteoporosis of the oldest old.Treatment of post-menopausal osteoporosis: beyond bisphosphonates.Pharmacological treatment of osteoporosis in the oldest old.Medical treatment of osteoporosis in the elderly.Intervention timing of strontium treatment on estrogen depletion-induced osteoporosis in rats: bone microstructure and mechanics.Effects of strontium ranelate administration on calcium metabolism in female patients with postmenopausal osteoporosis and primary hyperparathyroidism.
P2860
Q30235173-246DD7BC-3476-4C87-BDFB-0E9D364C0847Q30248776-3F209259-373B-49F5-97F6-5DF2BD1FB59DQ34099162-5EA2A429-A872-4917-9A8C-D708831E2391Q34272094-D4B3C54D-FF3B-4A2B-BA9E-15855FE8EA35Q34284002-33D26777-A7E6-4C4C-AE40-986C1DB821E9Q34585494-146F1B30-C1A0-4262-8A41-6A139A2D4FFFQ34585623-C18C2345-5CAD-42D3-88CB-96CA2E9D9206Q34612210-9823BE1A-8407-4D50-A91F-7A8989C65F2BQ34630644-3ABB3973-D9D4-42E1-8F08-EC3B50236A1FQ34727815-A97E88B5-5196-4886-AC1E-642EE84EF58EQ34751864-553C394C-08BF-4764-BE2F-F7E19372F550Q34902477-718B0408-4DD0-4B21-8348-51A9220011D6Q35667337-37EB3225-10AC-4E8B-8F8E-A651B33AEA63Q35830500-F61E68E5-088A-4BBF-8637-08F0F36AD1D4Q35892694-BED2D698-B1B6-4774-9765-A5AC6576C6E0Q36056938-49D0CAA0-D127-409B-94FA-96D4941483E1Q36100758-F021C460-750F-46BC-B076-773FA8C5CCA6Q36280067-783F608B-F36B-405D-BE7A-DC9FFFED0A3DQ36443755-A24F7DEB-5C22-41D2-B93B-C5EF73EB4B15Q36718819-D53137C2-867A-4AD9-B062-CBA1DE35906FQ36901419-6D5D03FE-E095-49E6-AE98-1057A4CD5553Q36944034-F946B39F-22EC-4A89-BF09-0A505ABE11D4Q36999717-73FEDBDB-DBAD-4723-95A7-53AE2B8CC819Q37156112-835F5B28-AC9B-46D7-9265-E1A0AD0862A3Q37199923-13BA1D9C-BF47-4C35-A0B5-6520EDD73286Q37401870-9C8AB89A-844D-421E-A759-FBA405FC4592Q37453973-1C7E440D-9762-42A9-8E1F-7189BDEB0437Q37777053-204ADE03-3328-4E5E-858E-22CA019066F8Q37807038-EC98A72C-6679-4504-AA03-B79F8F215847Q37843715-8F9D9AF9-5730-4EB5-B5CB-8D3FA7D48241Q37931985-F00F55C4-17C5-4C4B-9904-EA3CBB9AD125Q38014250-403B1088-D25D-41AF-A1CA-39C9A3512214Q38014515-E57C270C-AC7E-40F9-B85E-259414647F5BQ38124052-88FC9557-0552-42D9-B734-C74CC378F8F3Q38229503-3E8FD1D8-2EEB-4C09-B241-1ABBFD067058Q38246517-73FC70D6-504B-4E51-8937-A4309CF4148FQ39455613-75510DD8-46D1-46AB-A7FB-8E5C50680EE0Q43162470-88B99E74-AC85-40E1-89CC-760E8465D502Q44780305-C4312480-DD42-4B00-B116-4E6234ED8A92Q51302418-C9BF3C0E-26C5-486A-904F-F916EE0ABCE5
P2860
Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Strontium ranelate reduces the ...... eighty years of age and older.
@ast
Strontium ranelate reduces the ...... eighty years of age and older.
@en
type
label
Strontium ranelate reduces the ...... eighty years of age and older.
@ast
Strontium ranelate reduces the ...... eighty years of age and older.
@en
prefLabel
Strontium ranelate reduces the ...... eighty years of age and older.
@ast
Strontium ranelate reduces the ...... eighty years of age and older.
@en
P2093
P356
P1476
Strontium ranelate reduces the ...... eighty years of age and older.
@en
P2093
Alfredo Roces Varela
Carmelo Fiore
Claude Benhamou
Ego Seeman
Jean Marc Kaufman
Jean Pierre Aquino
Jean Yves Reginster
Jutta Semler
Krzysztof Hoszowski
Steven Boonen
P304
P356
10.1359/JBMR.060404
P577
2006-07-01T00:00:00Z